Your browser doesn't support javascript.
loading
Isocitrate dehydrogenase mutations in myeloid malignancies.
Medeiros, B C; Fathi, A T; DiNardo, C D; Pollyea, D A; Chan, S M; Swords, R.
Affiliation
  • Medeiros BC; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA, USA.
  • Fathi AT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Chan SM; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Swords R; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Leukemia ; 31(2): 272-281, 2017 02.
Article in En | MEDLINE | ID: mdl-27721426

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Isocitrate Dehydrogenase / Mutation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Isocitrate Dehydrogenase / Mutation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido